Janux Therapeutics, Inc. (JANX) stock
JANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3039% below fair value
$10.31−0.40 (-3.73%)
Close on Nov 18, 2026Market cap $630.32MP/E –Yield –
Janux Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Janux Therapeutics's market cap was $756.76M on Nov 11, 2026, against $2.05B a year earlier. Over the last 5 years it ranged from $268.79M to $2.82B, with a median of $867.72M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $756.76M | -8.8% |
| 2025 | Dec 31, 2025 | $829.71M | -70.4% |
| 2024 | Dec 31, 2024 | $2.80B | +465.9% |
| 2023 | Dec 29, 2023 | $495.20M | -9.5% |
| 2022 | Dec 30, 2022 | $547.22M | -32.6% |
| 2021 | Dec 31, 2021 | $812.32M | – |
See a number that looks wrong?